ProCE Banner Activity

我对2020年第23届国际艾滋病大会(线上)中3篇抗病毒治疗(ART)报告的看法

Conference Coverage
Clinical Thought
当前的HIV治疗方案是高度安全和有效的,但仍存在改善空间,并需要更多优化ART的信息支撑,包括针对初治严重HIV感染患者的ART方法的更多数据,减轻药物负担的简化策略,以及在二线治疗方案中核苷类抗逆转录病毒抑制剂(NRTI)筛选的最佳方法。根据2020年第23届国际艾滋病大会(线上)的报道,这是我针对其中3项相关研究的数据的看法。

Released: September 02, 2020

Expiration: September 01, 2021

No longer available for credit.

Share

Faculty

José R. Arribas

José R. Arribas, MD

Professor of Medicine
Department of Medicine
Autónoma University School of Medicine
Head, Infectious Diseases Unit
Department of Internal Medicine
Hospital La Paz
Madrid, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

教育拨款提供方:

Gilead

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

AIDS 2020

ProCE Banner

IAS 2018

ProCE Banner

Faculty Disclosure

Primary Author

José R. Arribas, MD

Professor of Medicine
Department of Medicine
Autónoma University School of Medicine
Head, Infectious Diseases Unit
Department of Internal Medicine
Hospital La Paz
Madrid, Spain

医学博士José R. Arribas披露他之前收到过Aelix、吉利德科学、杨森、默克、梯瓦制药和ViiV Healthcare的咨询费,以及吉利德科学、默克和ViiV Healthcare的研究资金。